Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel.

Meerum Terwogt JM, ten Bokkel Huinink WW, Schellens JH, Schot M, Mandjes IA, Zurlo MG, Rocchetti M, Rosing H, Koopman FJ, Beijnen JH.

Anticancer Drugs. 2001 Apr;12(4):315-23.

PMID:
11335787
2.

Safety, activity and estrogen inhibition by exemestane in postmenopausal women with advanced breast cancer: a phase I study.

Paridaens R, Thomas J, Wildiers J, Vermeiren P, Lobelle JP, di Salle E, Ornati G, Zurlo MG, Polli A, Lanzalone S, de Belder K.

Anticancer Drugs. 1998 Sep;9(8):675-83.

PMID:
9823425
3.

Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study.

Beran M, Jeha S, O'Brien S, Estey E, Vitek L, Zurlo MG, Rios MB, Keating M, Kantarjian H.

Clin Cancer Res. 1997 Dec;3(12 Pt 1):2377-84.

4.

Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group.

Thürlimann B, Paridaens R, Serin D, Bonneterre J, Roché H, Murray R, di Salle E, Lanzalone S, Zurlo MG, Piscitelli G.

Eur J Cancer. 1997 Oct;33(11):1767-73.

PMID:
9470830
5.

Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study.

Johannessen DC, Engan T, Di Salle E, Zurlo MG, Paolini J, Ornati G, Piscitelli G, Kvinnsland S, Lonning PE.

Clin Cancer Res. 1997 Jul;3(7):1101-8.

6.

Relapse after first cessation of therapy in childhood acute lymphoblastic leukemia: a 10-year follow-up study. Italian Association of Pediatric Hematology-Oncology (AIEOP).

Miniero R, Saracco P, Pastore G, Zurlo MG, Terracini B, Rosso P, Masera G.

Med Pediatr Oncol. 1995 Feb;24(2):71-6.

PMID:
7990766
7.

Phase I study of the novel distamycin derivative tallimustine (FCE 24517).

Sessa C, Pagani O, Zurlo MG, de Jong J, Hofmann C, Lassus M, Marrari P, Strolin Benedetti M, Cavalli F.

Ann Oncol. 1994 Dec;5(10):901-7.

PMID:
7696161
8.

Outcome of thalassemia treated with conventional therapy.

Borgna-Pignatti C, Zurlo MG, DeStefano P, Boffa C, DeSanctis V, DiPalma A, DiGregorio L, Melevendi C, Piga A, Sabato V.

Bone Marrow Transplant. 1993;12 Suppl 1:2-4. No abstract available.

PMID:
8374554
9.

Comparative in vitro myelotoxicity of FCE 24517, a distamycin derivative, to human, canine and murine hematopoietic progenitor cells.

Volpe DA, Du DL, Zurlo MG, Mongelli N, Murphy MJ.

Invest New Drugs. 1992 Nov;10(4):255-61.

PMID:
1487398
10.

Survival and causes of death in thalassaemia major.

Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, Di Gregorio F, Burattini MG, Terzoli S.

Lancet. 1989 Jul 1;2(8653):27-30.

PMID:
2567801
12.

Survival in thalassemia with conventional treatment.

Borgna-Pignatti C, Zurlo MG, DeStefano P, DiGregorio F, Di Palma A, Piga A, Melevendi C, Burattini MG, Terzoli S, Masera G.

Prog Clin Biol Res. 1989;309:27-33. No abstract available.

PMID:
2675094
13.

Treatment of acute lymphoblastic leukemia in children: the Italian (AIEOP) experience.

Paolucci G, Masera G, Vecchi V, Zanesco L, Madon E, Mandelli F, Massimo L, Tognoni G, Zurlo MG, Pession A.

Bone Marrow Transplant. 1989 Jan;4 Suppl 1:95-7. No abstract available.

PMID:
2653527
14.

Etoposide in recurrent childhood Langerhans' cell histiocytosis: an Italian cooperative study.

Ceci A, de Terlizzi M, Colella R, Balducci D, Toma MG, Zurlo MG, Macchia P, Mancini A, Indolfi P, Locurto M, et al.

Cancer. 1988 Dec 15;62(12):2528-31.

PMID:
3056605
15.

Insulin dependent diabetes in thalassaemia.

De Sanctis V, Zurlo MG, Senesi E, Boffa C, Cavallo L, Di Gregorio F.

Arch Dis Child. 1988 Jan;63(1):58-62.

16.

Height of children off therapy after acute lymphoblastic leukemia.

Zurlo MG, Senesi E, Terracini B, Balducci D, Biddau P, D'Angelo P, Rosati D, Gandus S, Madon E, Mancini A, et al.

Pediatr Hematol Oncol. 1988;5(3):187-95.

PMID:
3152964
17.

Prospective randomized comparison of two prophylactic regimens with trimethoprim-sulfamethoxazole in leukemic children: a two year study.

Rossi MR, Banfi P, Cappuccilli M, Conter V, de Poli D, Piacentini G, Zurlo MG, Masera G.

Eur J Cancer Clin Oncol. 1987 Nov;23(11):1679-82.

PMID:
3501375
18.

Late deaths and second primary malignancies among long-term survivors of childhood cancer: an Italian multicentre study.

Terracini B, Pastore G, Zurlo MG, Masera G, Fossati-Bellani F, Castello M, Tamaro P, Massolo F, Rosati D, Biddau PF, et al.

Eur J Cancer Clin Oncol. 1987 May;23(5):499-504.

PMID:
3653174
19.

Health status of young children with cancer following discontinuation of therapy.

Pastore G, Zurlo MG, Acquaviva A, Calculli G, Castello M, Ceci A, Di Tullio ML, Gandus S, Macchia P, Di Montezemolo LC, et al.

Med Pediatr Oncol. 1987;15(1):1-6.

PMID:
3470593
20.

Italian registry of patients off therapy after childhood acute lymphoblastic leukemia. Results after first phase of data collection.

Zurlo MG, Pastore G, Masera G, Terracini B, Burgio R, Ceci A, Digilio G, Guazzelli C, Haupt R, Lo Curto M, et al.

Cancer. 1986 Mar 1;57(5):1052-5.

PMID:
3455841
21.

Randomized multicentric Italian study on two treatment regimens for marrow relapse in childhood acute lymphoblastic leukemia.

Rossi MR, Masera G, Zurlo MG, Amadori S, Mandelli F, Bagnulo S, Carli M, Zanesco L, Dini G, Guazzelli C, et al.

Pediatr Hematol Oncol. 1986;3(1):1-9.

PMID:
3153213
22.

Urate-oxidase as hypouricemic agent in a case of acute tumor lysis syndrome.

Jankovic M, Zurlo MG, Rossi E, Edefonti A, Cossu MM, Giani M, Masera G.

Am J Pediatr Hematol Oncol. 1985 Summer;7(2):202-4. No abstract available.

PMID:
3870345
23.

[Therapy of acute lymphoblastic leukemia in children].

Masera G, Jankovic M, Uderzo C, Adamoli L, Locasciulli A, Rossi MR, Zurlo MG, Cantu' Rajnoldi A, Cattoretti G.

Recenti Prog Med. 1984 Oct;75(10):922-35. Review. Italian. No abstract available.

PMID:
6393242
24.

Quality of cancer care evaluation in Italy.

Liberati A, Masera G, Tognoni G, Zurlo MG.

Prog Clin Biol Res. 1983;130:455-63. No abstract available.

PMID:
6622479
25.

[Descriptive epidemiology of leukaemias in children aged 0-9 years, resident in the Lombardy region, 1974-1978].

Zurlo MG, Rossi MR, Pastore G, Marchi A, Ugazio AG, Masera G.

Haematologica. 1983 Jan-Feb;68(1):52-62. Italian. No abstract available.

PMID:
6404708
26.

Clinical relevance of terminal transferase and adenosine deaminase in leukemia.

Brusamolino E, Bertazzoni U, Isernia P, Ginelli E, Scovassi AI, Zurlo MG, Plevani P, Sacchi N, Bernasconi C.

Adv Exp Med Biol. 1982;145:279-303.

PMID:
7051780
27.

Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemia.

Masera G, Jankovic M, Zurlo MG, Locasciulli A, Rossi MR, Uderzo C, Recchia M.

J Pediatr. 1982 Jan;100(1):152-5. No abstract available.

PMID:
6948943
28.

[Idiopathic pulmonary hemosiderosis in childhood. Recent etiopathogenetic, diagnostic and therapeutic acquisitions].

Carnelli V, Zurlo MG, Giulotto P, Auriti L.

Minerva Pediatr. 1980 Jul 31;32(14):863-74. Review. Italian. No abstract available.

PMID:
7007858
29.

[Preleukemic states in infancy: discussion of 3 cases].

Pizzi E, Mauri A, Locasciulli A, Jankovic M, Zurlo MG, Carnelli V.

Minerva Pediatr. 1980 Jul 15;32(13):831-6. Italian. No abstract available.

PMID:
7194965
30.

[Efficacy of treatment with cyclophosphamide in a case of idiopathic pulmonary hemosiderosis].

Carnelli V, Biraghi V, Zurlo MG, Rossi MR, Parziani V.

Minerva Pediatr. 1979 Jun 15;31(11):893-900. Italian. No abstract available.

PMID:
470862

Supplemental Content

Loading ...
Support Center